healthmaking.

NewsMental Health & Therapy

Florida Health Department Warns Against Youth Psychiatric Drug Prescriptions

As WPEC reports from Tallahassee, Florida's Department of Health has issued new guidance urging physicians to step back from prescribing psychiatric medications to most children aged 5 to 17 for…

Florida Health Department Warns Against Youth Psychiatric Drug Prescriptions

As WPEC reports from Tallahassee, Florida's Department of Health has issued new guidance urging physicians to step back from prescribing psychiatric medications to most children aged 5 to 17 for depression, anxiety, and attention-deficit related conditions — and for any of us who has ever paused over a prescription and wondered whether we were truly helping or merely silencing a child, the move lands somewhere we already know intimately.

We recognize the pattern almost as soon as it's described: a brief appointment, a rising script, a young person who appears more manageable on the outside but harder to reach on the inside. The new Florida guidance, signed by State Surgeon General Dr. Joseph A. Ladapo during a Friday appearance in Orange County, formally names the tension so many of us have been quietly navigating.

What the guidance actually asks of clinicians

The Department of Health "cautions" health care providers against prescribing psychotropic medications for anxiety, depression, attention-deficit/hyperactivity disorder, and behavioral disorders in this age group, and instead recommends strategies such as psychotherapy, evidence-based behavior management, and deprescribing — the careful process of tapering medications that may no longer be serving the person taking them.

Agency for Health Care Administration Secretary Shevaun Harris framed it in a deliberately two-handed sentence: psychotropic medications can play an important role when clinically appropriate and medically necessary, but they should never substitute for individual therapy and other psychosocial care options. It deserves to be read twice, because it tries to honor both truths at once — and that is, honestly, the harder thing to do.

Why the context matters before we absorb the message

The guidance did not arrive in a vacuum. Two months earlier, HHS Secretary Robert F. Kennedy Jr. told a Make America Healthy Again summit in Washington, D.C. that the federal agency would address what he framed as the overuse of psychiatric medications among children. State officials, including Ladapo and First Lady Casey DeSantis, have spent the past year touring Florida under the Healthy Florida First initiative, which tests food for toxins and heavy metals; earlier in the year, Ladapo asked the Legislature to repeal all vaccine mandates, while DeSantis pushed pediatricians to accept patients regardless of vaccination status. Neither proposal passed.

So how we receive this guidance is, in part, an interpretive act. We are weighing a state recommendation that echoes a federal political project against a professional body that pushed back in May. The American Academy of Child and Adolescent Psychiatry, responding to HHS, said the federal statement "broadly and imprecisely challenges established psychiatric diagnoses and evidence-based treatments," and its president, Dr. John Walkup, urged that decisions about access to psychiatric medications and mental health services remain grounded in evidence and in the expertise of qualified clinicians. A Florida DOH spokesperson told reporters the new state guidelines do not contradict AACAP's position and are intended simply to raise awareness; the Florida chapters of both AACAP and the American Academy of Pediatrics could not be reached for comment.

A grounded way to walk into your next appointment

If there is one micro-habit worth taking from all of this, it is the three-question pause. Before any new psychiatric prescription — for a child, or honestly, for ourselves — we anchor ourselves by asking: what does this medication do that nothing else currently does; what are the specific risks we are agreeing to, in language we could repeat back to a friend; and what is the non-pharmacological plan sitting next to it in the file, with a name, a frequency, and someone accountable for carrying it forward.

The Florida advisory will be debated, celebrated, and condemned in equal measure. Our work, as the people sitting across from the prescriber, is quieter and more important. We slow down. We ask the third question. We leave the room knowing, in our own words, exactly what we just agreed to — and what we chose not to.